Biomarkers related to pulmonary fibrosis such as KL-6, SP-D, MMP-7, IL-6 have a great predictive potential in early diagnosis and treatment responsiveness in patients with post-COVID-19 pulmonary fibrosis. Here, MUC1 is linked to COVID-19.